217 related articles for article (PubMed ID: 10506125)
21. Peroxidative aggregation of alpha-synuclein requires tyrosines.
Olteanu A; Pielak GJ
Protein Sci; 2004 Nov; 13(11):2852-6. PubMed ID: 15459341
[TBL] [Abstract][Full Text] [Related]
22. Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide.
Kalivendi SV; Cunningham S; Kotamraju S; Joseph J; Hillard CJ; Kalyanaraman B
J Biol Chem; 2004 Apr; 279(15):15240-7. PubMed ID: 14742448
[TBL] [Abstract][Full Text] [Related]
23. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
24. Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole.
Kakimura J; Kitamura Y; Takata K; Kohno Y; Nomura Y; Taniguchi T
Eur J Pharmacol; 2001 Apr; 417(1-2):59-67. PubMed ID: 11301060
[TBL] [Abstract][Full Text] [Related]
25. Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
Dalfó E; Portero-Otín M; Ayala V; Martínez A; Pamplona R; Ferrer I
J Neuropathol Exp Neurol; 2005 Sep; 64(9):816-30. PubMed ID: 16141792
[TBL] [Abstract][Full Text] [Related]
26. alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells.
Hashimoto M; Hsu LJ; Rockenstein E; Takenouchi T; Mallory M; Masliah E
J Biol Chem; 2002 Mar; 277(13):11465-72. PubMed ID: 11790792
[TBL] [Abstract][Full Text] [Related]
27. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.
Duda JE; Giasson BI; Mabon ME; Lee VM; Trojanowski JQ
Ann Neurol; 2002 Aug; 52(2):205-10. PubMed ID: 12210791
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
29. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
30. Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions.
Dalfó E; Albasanz JL; Martin M; Ferrer I
Brain Pathol; 2004 Oct; 14(4):388-98. PubMed ID: 15605986
[TBL] [Abstract][Full Text] [Related]
31. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
32. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
33. Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle.
Uversky VN; Fink AL
FEBS Lett; 2002 Jul; 522(1-3):9-13. PubMed ID: 12095610
[TBL] [Abstract][Full Text] [Related]
34. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
35. Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments.
Jensen PH; Islam K; Kenney J; Nielsen MS; Power J; Gai WP
J Biol Chem; 2000 Jul; 275(28):21500-7. PubMed ID: 10764738
[TBL] [Abstract][Full Text] [Related]
36. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
37. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
Tsuchiya K; Tajima H; Kuwae T; Takeshima T; Nakano T; Tanaka M; Sunaga K; Fukuhara Y; Nakashima K; Ohama E; Mochizuki H; Mizuno Y; Katsube N; Ishitani R
Eur J Neurosci; 2005 Jan; 21(2):317-26. PubMed ID: 15673432
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
[TBL] [Abstract][Full Text] [Related]
39. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation.
Kanda S; Bishop JF; Eglitis MA; Yang Y; Mouradian MM
Neuroscience; 2000; 97(2):279-84. PubMed ID: 10799759
[TBL] [Abstract][Full Text] [Related]
40. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.
Galvin JE; Uryu K; Lee VM; Trojanowski JQ
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13450-5. PubMed ID: 10557341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
